Husam Younis

Husam Younis has a significant work experience in the biopharmaceutical industry. Husam currently holds the position of Senior Vice President at Avidity Biosciences, Inc., where they started in January 2023. Prior to this, they served as Vice President at the same company from December 2020 to December 2022. Before joining Avidity Biosciences, Inc., Husam was associated with NGM Biopharmaceuticals, where they held the role of Executive Director from August 2018 to December 2020. Husam also served as Senior Director at NGM Biopharmaceuticals from October 2014 to December 2020. Earlier in their career, Husam worked at Isis Pharmaceuticals as the Director of Nonclinical Development from June 2009 to October 2014. Husam began their professional journey at Pfizer, where they held the position of Director from 2002 to 2009.

Husam Younis has a strong educational background in the field of pharmacy and pharmaceutical sciences. Husam began their academic journey at the University of Arizona, where they completed their Doctor of Pharmacy (Pharm.D.) degree from 1992 to 1998. This degree provided him with a comprehensive understanding of pharmacy practices and medication management.

Building upon their Pharm.D., Husam pursued further specialization in the field of Pharmacology and Toxicology at the University of Arizona. From 1998 to 2001, they undertook a Doctor of Philosophy (Ph.D.) program, deepening their knowledge and expertise in this scientific discipline. This Ph.D. likely involved advanced coursework, independent research, and the completion of a dissertation focused on pharmacology and toxicology.

Unfortunately, no specific information is available regarding any subsequent education or degrees after completing their Ph.D. at the University of Arizona.